%0 Journal Article
%T T Cell-Redirecting Strategies to ¡®STAb¡¯ Tumors: Beyond CARs and Bispecific Antibodies
%J -
%D 2019
%R https://doi.org/10.1016/j.it.2019.01.008
%X Current FDA-approved strategies geared towards redirecting T cell activation against tumor cells include the expression of chimeric antigen receptors (CARs) by T cells, and the passive administration of bispecific antibodies (bsAbs) targeting CD3 and a TAA
%U https://www.cell.com/trends/immunology/fulltext/S1471-4906(19)30008-0